| Code | 4508E | ||||||||||
| MA number | 18/0428/16-S | ||||||||||
| Product Form: | tbl flm 250x100 mg (fľ.HDPE - nemocn.bal.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | TEVA Pharmaceuticals Slovakia s.r.o., Slovakia | ||||||||||
| Therapeutic Class: | 18 - ANTIDIABETICA (VRÁTANE INZULÍNU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 21.09.2016 |
| PIL: |
PIL_Sitagliptin Teva_10.2023.pdf
|
| SPC: |
SPC_Sitagliptin Teva_10.2023.pdf
|
| Safety feature | Yes |
| Data update: | 03.10.2023 |
